1. Home
  2. KIDS vs IVVD Comparison

KIDS vs IVVD Comparison

Compare KIDS & IVVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OrthoPediatrics Corp.

KIDS

OrthoPediatrics Corp.

HOLD

Current Price

$16.43

Market Cap

401.2M

Sector

Health Care

ML Signal

HOLD

Logo Invivyd Inc.

IVVD

Invivyd Inc.

HOLD

Current Price

$1.80

Market Cap

437.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KIDS
IVVD
Founded
2007
2020
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
401.2M
437.1M
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
KIDS
IVVD
Price
$16.43
$1.80
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
5
Target Price
$24.67
$8.75
AVG Volume (30 Days)
146.6K
3.5M
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
79.02
EPS
N/A
N/A
Revenue
$98,049,000.00
$53,426,000.00
Revenue This Year
$14.07
$147.67
Revenue Next Year
$11.85
$22.76
P/E Ratio
N/A
N/A
Revenue Growth
37.95
110.47
52 Week Low
$14.91
$0.46
52 Week High
$23.70
$3.07

Technical Indicators

Market Signals
Indicator
KIDS
IVVD
Relative Strength Index (RSI) 49.34 60.99
Support Level $15.70 $1.41
Resistance Level $19.15 $2.00
Average True Range (ATR) 0.68 0.14
MACD 0.06 0.06
Stochastic Oscillator 79.21 99.21

Price Performance

Historical Comparison
KIDS
IVVD

About KIDS OrthoPediatrics Corp.

OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercializes implants and instruments to meet the needs of surgeons and patients. Its products include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia, and ACL Reconstruction System, among others. The company operates in one operating and reportable segment, OrthoPediatrics, which designs, develops, and markets anatomically appropriate specialized braces, implants, and devices for children with orthopedic problems.

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

Share on Social Networks: